UK markets closed

Novo Nordisk A/S (NVO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
127.23+2.64 (+2.12%)
As of 02:22PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3388
Avg. Estimate0.740.783.394.08
Low estimate0.680.753.23.59
High estimate0.80.823.694.82
Year ago EPS0.640.632.663.39
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3477
Avg. Estimate9.1B9.86B41.7B49.9B
Low estimate8.76B9.61B39.92B44.74B
High estimate9.55B10.25B43.2B53.97B
Year ago sales7.59B7.97B33.13B41.7B
Sales growth (year/est)20.00%23.80%25.90%19.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS0.630.650.730.64
Actual EPS0.640.630.730.7
Difference0.01-0.0200.06
Surprise %1.60%-3.10%0.00%9.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.740.783.394.08
7 days ago0.740.773.364.04
30 days ago0.740.773.343.97
60 days ago0.790.83.353.97
90 days ago0.780.83.243.85
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1211
Up last 30 days1255
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesNVOIndustrySector(s)S&P 500
Current qtr.15.60%N/AN/AN/A
Next qtr.23.80%N/AN/AN/A
Current year27.40%N/AN/AN/A
Next year20.40%N/AN/AN/A
Next 5 years (per annum)2.80%N/AN/AN/A
Past 5 years (per annum)19.23%N/AN/AN/A